Cargando…
Transthyretin as a novel candidate biomarker for preeclampsia
Preeclampsia (PE) is considered to be a potentially fatal complication during pregnancy. However, no effective laboratory assessment has been developed to enable early diagnosis and monitoring of PE. The present study aimed to identify differentially expressed transthyretin (TTR) during severe PE an...
Autores principales: | ZHU, LEI, CHEN, YUXUAN, LIU, CHONGDONG, DENG, HAITENG, ZHANG, NAWEI, WANG, SHENGDIAN, ZHANG, ZHENYU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991523/ https://www.ncbi.nlm.nih.gov/pubmed/24940434 http://dx.doi.org/10.3892/etm.2014.1558 |
Ejemplares similares
-
Proteomics Analysis for Finding Serum Markers of Ovarian Cancer
por: Cheng, Yushan, et al.
Publicado: (2014) -
Supplementation of folic acid in pregnancy and the risk of preeclampsia and gestational hypertension: a meta-analysis
por: Liu, Cheng, et al.
Publicado: (2018) -
RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway
por: Li, Hongxia, et al.
Publicado: (2018) -
Expression and prognostic value of CLIC1 in epithelial ovarian cancer
por: Yu, Wentao, et al.
Publicado: (2018) -
Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics
por: Qu, Hong, et al.
Publicado: (2016)